IS5005A - Nucleic acids and amino acids related to Helicobacter pylori and their vaccines - Google Patents

Nucleic acids and amino acids related to Helicobacter pylori and their vaccines

Info

Publication number
IS5005A
IS5005A IS5005A IS5005A IS5005A IS 5005 A IS5005 A IS 5005A IS 5005 A IS5005 A IS 5005A IS 5005 A IS5005 A IS 5005A IS 5005 A IS5005 A IS 5005A
Authority
IS
Iceland
Prior art keywords
vaccines
helicobacter pylori
amino acids
nucleic acids
acids
Prior art date
Application number
IS5005A
Other languages
Icelandic (is)
Inventor
Smith Douglas
A. Alm Richard
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS5005A publication Critical patent/IS5005A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
IS5005A 1996-10-28 1999-03-18 Nucleic acids and amino acids related to Helicobacter pylori and their vaccines IS5005A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US75973996A 1996-12-06 1996-12-06
US89192897A 1997-07-14 1997-07-14
PCT/US1997/019575 WO1998018323A1 (en) 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (1)

Publication Number Publication Date
IS5005A true IS5005A (en) 1999-03-18

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5005A IS5005A (en) 1996-10-28 1999-03-18 Nucleic acids and amino acids related to Helicobacter pylori and their vaccines

Country Status (19)

Country Link
EP (1) EP0973394A4 (en)
JP (1) JP2001504329A (en)
KR (1) KR20000052831A (en)
CN (1) CN1235513A (en)
AR (1) AR009600A1 (en)
AU (1) AU734052B2 (en)
BR (1) BR9712587A (en)
CA (1) CA2265523A1 (en)
EE (1) EE9900176A (en)
ID (1) ID22065A (en)
IL (1) IL129397A0 (en)
IS (1) IS5005A (en)
NO (1) NO991995L (en)
NZ (1) NZ334568A (en)
PL (1) PL333169A1 (en)
SA (1) SA98180918A (en)
SK (1) SK34699A3 (en)
TR (1) TR199900940T2 (en)
WO (1) WO1998018323A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003824A1 (en) * 1993-07-27 1995-02-09 Csl Limited Treatment of h. pylori associated gastroduodenal disease
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
DE19730425A1 (en) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heat-curing laundry-resistant shell sealant
WO2000006743A2 (en) * 1998-07-27 2000-02-10 Connaught Laboratories Limited Chlamydia antigens and corresponding dna fragments and uses thereof
SE9901548D0 (en) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
CN101532001A (en) 2000-03-08 2009-09-16 诺维信公司 Variants with altered properties
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
US9359627B2 (en) 2011-03-17 2016-06-07 National University Corporation Mie University Antibody production method
US10828358B2 (en) * 2015-12-14 2020-11-10 Technische Universität München Helicobacter pylori vaccines
CN115724922B (en) * 2022-07-19 2023-08-22 四川大学华西医院 Helicobacter pylori vaccine recombinant protein antigen TonB, preparation method and application thereof
CN115581201A (en) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 Diploid rose F induced by stem segment as explant 1 -61 plant regeneration method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (en) * 1993-01-19 1994-07-20 Medicarb Ab Preparation of a new drug

Also Published As

Publication number Publication date
TR199900940T2 (en) 1999-09-21
EP0973394A1 (en) 2000-01-26
AU734052B2 (en) 2001-05-31
JP2001504329A (en) 2001-04-03
KR20000052831A (en) 2000-08-25
IL129397A0 (en) 2000-02-17
EP0973394A4 (en) 2005-03-30
NZ334568A (en) 2000-04-28
BR9712587A (en) 1999-10-26
CA2265523A1 (en) 1998-05-07
NO991995D0 (en) 1999-04-27
EE9900176A (en) 1999-12-15
SA98180918A (en) 2005-12-03
AU5093398A (en) 1998-05-22
PL333169A1 (en) 1999-11-22
NO991995L (en) 1999-06-28
AR009600A1 (en) 2000-04-26
WO1998018323A1 (en) 1998-05-07
SK34699A3 (en) 2000-04-10
ID22065A (en) 1999-08-26
CN1235513A (en) 1999-11-17

Similar Documents

Publication Publication Date Title
IS4615A (en) Antigen Helicobacter pylori and vaccine preparations
NO975745L (en) Nucleic acid and amino acid sequences related to Heliobacter Pylori for diagnostics and therapy
DK0909327T3 (en) Erythromycins and Methods for their Preparation
DK0954588T3 (en) OB fusion protein compositions and methods
IS5005A (en) Nucleic acids and amino acids related to Helicobacter pylori and their vaccines
DE69334197D1 (en) Helicobacter pylori cytotoxin useful in vaccines and diagnostics
NO970762D0 (en) Well-string firing locator and method thereof
NO984517D0 (en) Nucleic acid and amino acid sequences related to Helicobacter pylori and vaccine mixtures thereof
IS5047A (en) Nucleic and amino acid sequences related to Helicobacter pylori and their vaccines
NO992091L (en) Pharmaceutical surface preparations containing lamivudine and zidovudine
DK108990A (en) PIG DYSENTERY PUBLIC VACCINE AND PROCEDURE FOR PREPARING THEREOF
IS4630A (en) Nucleic and amino acid sequences for Helicobacter Pylori for diagnostic and therapeutic purposes
ZA979672B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine composition thereof
ZA972715B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof.
ZA9710971B (en) Nucleic acid and amino acid sequences relating to Helicobacter pylori and vaccine compositions thereof.
HUP9903843A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP0000521A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
ZA955499B (en) Helicobacter proteins and vaccines
GB9413050D0 (en) Helicobacter pylori carbonic anhydrase-like protein
IL116541A0 (en) Helicobacter proteins and vaccines